Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 448,029
  • Shares Outstanding, K 41,217
  • Annual Sales, $ 292,500 K
  • Annual Income, $ -33,990 K
  • EBIT $ -22 M
  • EBITDA $ 4 M
  • 60-Month Beta 0.48
  • Price/Sales 1.54
  • Price/Cash Flow 22.38
  • Price/Book 2.55

Options Overview Details

View History
  • Implied Volatility 76.71% (+0.19%)
  • Historical Volatility 30.70%
  • IV Percentile 77%
  • IV Rank 56.58%
  • IV High 106.24% on 07/14/25
  • IV Low 38.24% on 10/23/25
  • Expected Move (DTE 17) 2.04 (18.05%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 118
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 1,947
  • Open Int (30-Day) 2,230
  • Expected Range 9.26 to 13.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/26
See More
  • Average Estimate $-0.11
  • Number of Estimates 2
  • High Estimate $-0.10
  • Low Estimate $-0.11
  • Prior Year $0.03
  • Growth Rate Est. (year over year) -466.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.31 +9.51%
on 03/20/26
11.69 -3.42%
on 03/02/26
-0.15 (-1.31%)
since 02/27/26
3-Month
9.72 +16.15%
on 01/12/26
13.37 -15.56%
on 01/05/26
-1.81 (-13.82%)
since 12/26/25
52-Week
8.36 +35.05%
on 08/08/25
13.99 -19.30%
on 12/04/25
+1.79 (+18.84%)
since 03/28/25

Most Recent Stories

More News
AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.28 (+3.77%)
U.S. Jobs Figures Issued in Short Week

MondayFeatured Earnings Maze Therpautics (NASDAQ:MAZE) (Q4) EPS for loss of 73 cents, compared ...

AYI : 276.02 (+1.32%)
MKC : 50.45 (-6.09%)
FDS : 215.05 (+5.13%)
MSM : 91.66 (+1.88%)
CAG : 15.62 (-0.70%)
NKE : 52.67 (+2.79%)
PRGS : 25.31 (-10.47%)
POET : 5.91 (+16.34%)
LW : 41.71 (+1.86%)
ANGO : 11.28 (+3.77%)
MAZE : 30.05 (+3.58%)
LNN : 118.99 (+1.16%)
AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.28 (+3.77%)
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.28 (+3.77%)
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform

Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Option for Major Solid Tumor Types

ANGO : 11.28 (+3.77%)
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care

The ALPHA-PE Research Fund Supports Independent, Physician-Led Studies to Advance Real-World PE Evidence

ANGO : 11.28 (+3.77%)
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio

ANGO : 11.28 (+3.77%)
AngioDynamics: Fiscal Q2 Earnings Snapshot

AngioDynamics: Fiscal Q2 Earnings Snapshot

ANGO : 11.28 (+3.77%)
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability

Med Tech segment delivers fifth consecutive quarter of double-digit growth Strong adjusted EBITDA; and positive cash flow Three regulatory milestones support Mechanical...

ANGO : 11.28 (+3.77%)
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and...

ANGO : 11.28 (+3.77%)

Business Summary

AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies...

See More

Key Turning Points

3rd Resistance Point 11.24
2nd Resistance Point 11.07
1st Resistance Point 10.97
Last Price 11.28
1st Support Level 10.70
2nd Support Level 10.53
3rd Support Level 10.43

See More

52-Week High 13.99
Fibonacci 61.8% 11.84
Last Price 11.28
Fibonacci 50% 11.17
Fibonacci 38.2% 10.51
52-Week Low 8.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.